1. Home
  2. HOTH vs GENK Comparison

HOTH vs GENK Comparison

Compare HOTH & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hoth Therapeutics Inc.

HOTH

Hoth Therapeutics Inc.

HOLD

Current Price

$1.36

Market Cap

11.7M

Sector

Health Care

ML Signal

HOLD

Logo GEN Restaurant Group Inc.

GENK

GEN Restaurant Group Inc.

HOLD

Current Price

$1.92

Market Cap

12.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOTH
GENK
Founded
2017
2011
Country
United States
United States
Employees
N/A
2700
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
12.8M
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
HOTH
GENK
Price
$1.36
$1.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$5.00
$4.50
AVG Volume (30 Days)
7.9M
28.4K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
1.88%
EPS Growth
29.69
62.50
EPS
N/A
N/A
Revenue
N/A
$208,380,000.00
Revenue This Year
N/A
$4.79
Revenue Next Year
N/A
$7.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.12
52 Week Low
$0.49
$1.43
52 Week High
$2.12
$4.98

Technical Indicators

Market Signals
Indicator
HOTH
GENK
Relative Strength Index (RSI) 84.55 48.04
Support Level $1.28 $1.53
Resistance Level $1.47 $2.45
Average True Range (ATR) 0.10 0.19
MACD 0.05 -0.04
Stochastic Oscillator 81.19 32.25

Price Performance

Historical Comparison
HOTH
GENK

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA). Its current assets are focused in treating cancer, skin toxicities, Alzheimer's, and weight loss.

About GENK GEN Restaurant Group Inc.

GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. The group operates its restaurants in California, Arizona, Hawaii, Nevada, Texas, New York, Oregon, North Carolina, Washington, New Jersey, Florida and South Korea.

Share on Social Networks: